RESGEN (RESGEN) Fair Value & Analysis
IN · Market cap ₹999M
Fair value as of: Jul 5, 2026
From 24 valuation models · updated today
Share price −13.5% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹47.62 – ₹94.29 · fair‑value band ₹44.64 – ₹103.49 · the ₹47.62 price screens below the ₹82.51 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
RESGEN (RESGEN) currently trades at ₹47.62, while our model-based Fair Value estimate is ₹82.51 — implying the stock looks roughly 73.3% undervalued today. We read business quality at 50/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, RESGEN generated revenue of ₹727M at a net margin of 12.1%. Revenue grew 76.6% year over year. It earns a return on equity of 14.0%. Net debt stands at ₹29.0M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹44.64 (bear case) to ₹103.49 (bull case); at ₹47.62, the current price sits within that range. The share trades about 52% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
RESGEN reported revenue of ₹711M in FY2026 versus ₹48.1M in FY2022, a compound +96.1%/yr. Reported net income was ₹87.7M in FY2026, compounding +84.5%/yr from FY2022.
Is RESGEN fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is RESGEN (RESGEN) undervalued?
What is the fair value of RESGEN?
What is the quality score of RESGEN?
What is the revenue of RESGEN (RESGEN)?
What is the net profit margin of RESGEN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.